Impaired Amino Acid Transport At The Blood Brain Barrier Is A Cause Of Autism Spectrum Disorder
Tarih
2016Yazar
Tarlungeanu, Dora C.
Deliu, Elena
Dotter, Christoph P.
Kara, Majdi
Janiesch, Philipp Christoph
Scalise, Mariafrancesca
Galluccio, Michele
Tesulov, Mateja
Morelli, Emanuela
Sonmez, Fatma Mujgan
Bilguvar, Kaya
Ohgaki, Ryuichi
Kanai, Yoshikatsu
Johansen, Anide
Esharif, Seham
Ben-Omran, Tawfeg
Topcu, Meral
Schlessinger, Avner
Indiveri, Cesare
Duncan, Kent E.
Caglayan, Ahmet Okay
Gunel, Murat
Gleeson, Joseph G.
Novarino, Gaia
Üst veri
Tüm öğe kaydını gösterÖzet
Autism spectrum disorders (ASD) are a group of genetic disorders often overlapping with other neurological conditions. We previously described abnormalities in the branched-chain amino acid (BCAA) catabolic pathway as a cause of ASD. Here, we show that the solute carrier transporter 7a5 (SLC7A5), a large neutral amino acid transporter localized at the bloodbrainbarrier (BBB), has an essential role in maintaining normal levels of brain BCAAs. In mice, deletion of Slc7a5 from the endothelial cells of theBBBleads to atypical brain amino acid profile, abnormal mRNA translation, and severe neurological abnormalities. Furthermore, we identified several patients with autistic traits and motor delay carrying deleterious homozygous mutations in the SLC7A5 gene. Finally, we demonstrate that BCAA intracerebroventricular administration ameliorates abnormal behaviors in adult mutant mice. Our data elucidate a neurological syndrome defined by SLC7A5 mutations and support an essential role for the BCAA in human brain function.